Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Hair follicle analysis can track body changes from high-intensity interval training.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Fenugreek seeds and Butea monosperma flowers may help reduce hair loss from chemotherapy.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

A new method accurately measures long-term hormone levels in hair.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

A single injection of PTH–CBD can increase bone density for up to a year.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The TrichoConcept™ line is effective for personalized hair loss treatments.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.